NASDAQ:LQDA
Liquidia Technologies Inc. Stock News
$12.42
-0.420 (-3.27%)
At Close: May 24, 2024
Liquidia: Q2 Earnings Insights
07:08am, Tuesday, 10'th Aug 2021
Shares of Liquidia (NASDAQ:LQDA) fell 0.8% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 73.47% year over year to ($0.13), which beat the estim
Liquidia Reports Second Quarter 2021 Financial Results and Provides Corporate Update
07:00am, Tuesday, 10'th Aug 2021
MORRISVILLE, N.C., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (“Liquidia” or the “Company”) today reported financial results for the quarter ended June 30, 2021. The
Liquidia: Martine Rothblatt's United Therapeutics Is Tough To Beat
09:42am, Monday, 09'th Aug 2021
LQDA is trying to bring a Tyvaso competitor to the market that allegedly works better. United is doing all it can to stop that.
Liquidia Announces Generic Treprostinil Injection Now Also Available for Subcutaneous Route of Administration
04:05pm, Monday, 24'th May 2021
Sandoz Generic Treprostinil Injection now available for both routes of administration, subcutaneous and intravenous Sandoz Generic Treprostinil Injection now available for both routes of administratio
Liquidia Technologies, Inc. (LQDA) Reports Q1 Loss, Tops Revenue Estimates
12:55pm, Thursday, 13'th May 2021
Liquidia Technologies, Inc. (LQDA) delivered earnings and revenue surprises of -5.00% and 260.28%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the
Liquidia Technologies, Inc. (LQDA) CEO Damian deGoa on Q1 2021 Results - Earnings Call Transcript
12:08pm, Thursday, 13'th May 2021
Liquidia Technologies, Inc. (LQDA) CEO Damian deGoa on Q1 2021 Results - Earnings Call Transcript
MORRISVILLE, N.C., May 10, 2021 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that on May 7, 2021, it resubmitted its New Drug Application (NDA) for LIQ861 for the treatment
Rising P/E: An Overlooked Way to Pick 5 Winning Stocks
06:46am, Thursday, 29'th Apr 2021
Want to try an out-of-the-box approach? Tap five stocks with increasing P/E ratios.
Liquidia Announces Generic Treprostinil Injection Will Be Available for Subcutaneous Route of Administration
07:00am, Tuesday, 30'th Mar 2021
RESEARCH TRIANGLE PARK, N.C., March 30, 2021 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (“Liquidia” or the “Company”) today announced that Treprostinil Injection, a generic form o
Liquidia Technologies, Inc. (LQDA) CEO Damian deGoa on Q4 2020 Results - Earnings Call Transcript
01:05pm, Tuesday, 23'rd Mar 2021
Liquidia Technologies, Inc. (LQDA) CEO Damian deGoa on Q4 2020 Results - Earnings Call Transcript
Liquidia Corporation to Host 2020 Financial Results Conference Call on March 23, 2021
07:30am, Tuesday, 09'th Mar 2021
RESEARCH TRIANGLE PARK, N.C., March 09, 2021 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced that 2020 financial results will be reported on Tuesday, March 23, 2021. The compan
Liquidia Corporation Secures $20.5 Million Debt Facility with Silicon Valley Bank
08:30am, Tuesday, 02'nd Mar 2021
RESEARCH TRIANGLE PARK, N.C., March 02, 2021 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced the closing of a debt facility on February 26, 2021, with Silicon Valley Bank, whic
LOS ANGELES--(BUSINESS WIRE)---- $LQDA #LQDA--INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Liquidia Corporation.
LOS ANGELES--(BUSINESS WIRE)---- $LQDA #LQDA--INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Liquidia Corporation.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Liquidia Corporation - LQDA
12:05am, Sunday, 20'th Dec 2020
NEW YORK, Dec. 20, 2020 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Liquidia Corporation (“Liquidia” or the “Company”) (NASDAQ: LQDA). Such investor